VanEck Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140M | Sell |
|
|||||
|
2025
Q1 | $380M | Sell |
|
|||||
|
2024
Q4 | $566M | Sell |
|
|||||
|
2024
Q3 | $553M | Buy |
|
|||||
|
2024
Q2 | $434M | Buy |
|
|||||
|
2024
Q1 | $408M | Buy |
|
|||||
|
2023
Q4 | $404M | Buy |
|
|||||
|
2023
Q3 | $340M | Buy |
|
|||||
|
2023
Q2 | $295M | Buy |
|
|||||
|
2023
Q1 | $166M | Buy |
|
|||||
|
2022
Q4 | $170M | Sell |
|
|||||
|
2022
Q3 | $226M | Sell |
|
|||||
|
2022
Q2 | $239M | Buy |
|
|||||
|
2022
Q1 | $212M | Buy |
|
|||||
|
2021
Q4 | $241M | Buy |
|
|||||
|
2021
Q3 | $222M | Buy |
|
|||||
|
2021
Q2 | $204M | Buy |
|
|||||
|
2021
Q1 | $165M | Buy |
|
|||||
|
2020
Q4 | $129M | Buy |
|
|||||
|
2020
Q3 | $119M | Buy |
|
|||||
|
2020
Q2 | $135M | Buy |
|
|||||
|
2020
Q1 | $118M | Sell |
|
|||||
|
2019
Q4 | $111M | Buy |
|
|||||
|
2019
Q3 | $89.4M | Buy |
|
|||||
|
2019
Q2 | $94.6M | Buy |
|
|||||
|
2019
Q1 | $84.3M | Buy |
|
|||||
|
2018
Q4 | $67.4M | Buy |
|
|||||
|
2018
Q3 | $79.3M | Buy |
|
|||||
|
2018
Q2 | $57.4M | Sell |
|
|||||
|
2018
Q1 | $63.3M | Sell |
|
|||||
|
2017
Q4 | $77.4M | Buy |
|
|||||
|
2017
Q3 | $86.3M | Sell |
|
|||||
|
2017
Q2 | $101M | Buy |
|
|||||
|
2017
Q1 | $95.9M | Buy |
|
|||||
|
2016
Q4 | $86.6M | Buy |
|
|||||
|
2016
Q3 | $88M | Buy |
|
|||||
|
2016
Q2 | $88.8M | Sell |
|
|||||
|
2016
Q1 | $105M | Buy |
|
|||||
|
2015
Q4 | $91.8M | Sell |
|
|||||
|
2015
Q3 | $105M | Sell |
|
|||||
|
2015
Q2 | $127M | Sell |
|
|||||
|
2015
Q1 | $151M | Buy |
|
|||||
|
2014
Q4 | $83.5M | Buy |
|
|||||
|
2014
Q3 | $84.6M | Sell |
|
|||||
|
2014
Q2 | $73.2M | Sell |
|
|||||
|
2014
Q1 | $69.3M | Buy |
|
|||||
|
2013
Q4 | $70.9M | Buy |
|
|||||
|
2013
Q3 | $55.5M | Buy |
|
|||||
|
2013
Q2 | $31.5M | Buy |
|